---
figid: PMC6736652__cjcr-31-4-586-1
figlink: /pmc/articles/PMC6736652/figure/Figure1/
number: F1
caption: Overview of predictive biomarkers for bevacizumab efficacy in breast cancer.
  (A) Polymorphisms of several genes correlate with aberrant expression of critical
  proteins in angiogenic pathway; (B) Application of novel imaging methods allows
  in vivo tracing of bevacizumab perfusion in tumor tissues, and visualizing how they
  function on tumor; (C) Circulating angiogenic factors and endothelial cells promote
  neo-angiogenesis directly, and may serve as a noninvasive approach to assess angiogenic
  activities of tumors; (D) Combinations of multiple gene variables, tumor microvascular
  density or tumor characteristics profile the hallmark of breast cancer. SNP, single-nucleotide
  polymorphism; VEGF, vascular endothelial growth factor; IL-8, interleukin 8; AGTR1,
  angiotensin II receptor 1; RGD-USPIO, arginine-glycine-aspartic acid-labeled ultrasmall
  superparamagnetic iron oxide nanoparticles; VEGFR, vascular endothelial growth factor
  receptor; MMP, matrix metalloproteinases; CEC, circulating endothelial cell; CEP,
  circulating endothelial progenitor cell; Dll4, delta-like ligand 4; MVD, microvascular
  density.
pmcid: PMC6736652
papertitle: 'An update on biomarkers of potential benefit with bevacizumab for breast
  cancer treatment: Do we make progress?.'
reftext: Xu Liang, et al. Chin J Cancer Res. 2019 Aug;31(4):586-600.
pmc_ranked_result_index: '153418'
pathway_score: 0.5322269
filename: cjcr-31-4-586-1.jpg
figtitle: Predictive biomarkers for bevacizumab efficacy in breast cancer
year: '2019'
organisms: Homo sapiens
ndex: 1d477f19-deab-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6736652__cjcr-31-4-586-1.html
  '@type': Dataset
  description: Overview of predictive biomarkers for bevacizumab efficacy in breast
    cancer. (A) Polymorphisms of several genes correlate with aberrant expression
    of critical proteins in angiogenic pathway; (B) Application of novel imaging methods
    allows in vivo tracing of bevacizumab perfusion in tumor tissues, and visualizing
    how they function on tumor; (C) Circulating angiogenic factors and endothelial
    cells promote neo-angiogenesis directly, and may serve as a noninvasive approach
    to assess angiogenic activities of tumors; (D) Combinations of multiple gene variables,
    tumor microvascular density or tumor characteristics profile the hallmark of breast
    cancer. SNP, single-nucleotide polymorphism; VEGF, vascular endothelial growth
    factor; IL-8, interleukin 8; AGTR1, angiotensin II receptor 1; RGD-USPIO, arginine-glycine-aspartic
    acid-labeled ultrasmall superparamagnetic iron oxide nanoparticles; VEGFR, vascular
    endothelial growth factor receptor; MMP, matrix metalloproteinases; CEC, circulating
    endothelial cell; CEP, circulating endothelial progenitor cell; Dll4, delta-like
    ligand 4; MVD, microvascular density.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - C7orf49
  - CXCL8
  - MMP2
  - MMP9
  - KDR
  - MVD
  - VEGFA
  - AGTR1
  - VEGFC
  - FLT4
  - PGF
  - FLT1
  - VEGFB
  - VEGFD
  - Zr
genes:
- word: MRI
  symbol: MRI
  source: hgnc_alias_symbol
  hgnc_symbol: C7orf49
  entrez: '78996'
- word: IL-8
  symbol: IL-8
  source: hgnc_alias_symbol
  hgnc_symbol: CXCL8
  entrez: '3576'
- word: MMP2/MMP9
  symbol: MMP2
  source: hgnc_symbol
  hgnc_symbol: MMP2
  entrez: '4313'
- word: MMP2/MMP9
  symbol: MMP9
  source: hgnc_symbol
  hgnc_symbol: MMP9
  entrez: '4318'
- word: VEGFR-2
  symbol: VEGFR2
  source: hgnc_alias_symbol
  hgnc_symbol: KDR
  entrez: '3791'
- word: MVD
  symbol: MVD
  source: hgnc_symbol
  hgnc_symbol: MVD
  entrez: '4597'
- word: VEGF-A
  symbol: VEGF-A
  source: hgnc_alias_symbol
  hgnc_symbol: VEGFA
  entrez: '7422'
- word: AGTR1
  symbol: AGTR1
  source: hgnc_symbol
  hgnc_symbol: AGTR1
  entrez: '185'
- word: VEGF/VEGFR
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFC
  entrez: '7424'
- word: VEGFR-3
  symbol: VEGFR3
  source: hgnc_alias_symbol
  hgnc_symbol: FLT4
  entrez: '2324'
- word: VEGF/VEGFR
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: PGF
  entrez: '5228'
- word: VEGF/VEGFR
  symbol: VEGFR
  source: bioentities_symbol
  hgnc_symbol: KDR
  entrez: '3791'
- word: VEGFR-1
  symbol: VEGFR1
  source: hgnc_alias_symbol
  hgnc_symbol: FLT1
  entrez: '2321'
- word: VEGF/VEGFR
  symbol: VEGFR
  source: bioentities_symbol
  hgnc_symbol: FLT1
  entrez: '2321'
- word: VEGF/VEGFR
  symbol: VEGFR
  source: bioentities_symbol
  hgnc_symbol: FLT4
  entrez: '2324'
- word: VEGF/VEGFR
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFB
  entrez: '7423'
- word: VEGF/VEGFR
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFD
  entrez: '2277'
- word: VEGF/VEGFR
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFA
  entrez: '7422'
chemicals:
- word: Zr
  source: MESH
  identifier: D015040
diseases: []
figid_alias: PMC6736652__F1
redirect_from: /figures/PMC6736652__F1
figtype: Figure
---
